GALR1 and colorectal carcinoma: Compared to epithelial cells of the large intestine, a stronger immunoreactivity for GAL1R/GAL3R was observed in CRC cells and it has been reported that the high expression of GAL3R in CRC tissue was associated with a better prognosis and longer survival of CRC patients; this means that GAL3R is a prognostic factor for these patients [184].